BA
SGYP

BlackRock Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

BlackRock Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$853K Buy
140,042
+1,135
+0.8% +$5.93K ﹤0.01% 1938
2016
Q3 		$765K Buy
138,907
+52,362
+61% +$245K ﹤0.01% 1955
2016
Q2 		$329K Buy
86,545
+41,794
+93% +$142K ﹤0.01% 2350
2016
Q1 		$124K Buy
44,751
+3,122
+7% +$11.3K ﹤0.01% 2819
2015
Q4 		$236K Sell
41,629
-20,805
-33% -$127K ﹤0.01% 2487
2015
Q3 		$331K Sell
62,434
-1,128
-2% -$8.73K ﹤0.01% 2459
2015
Q2 		$528K Buy
63,562
+9,031
+17% +$43.8K ﹤0.01% 2141
2015
Q1 		$252K Buy
54,531
+7,875
+17% +$25.6K ﹤0.01% 2547
2014
Q4 		$142K Sell
46,656
-3,291
-7% -$9.73K ﹤0.01% 2847
2014
Q3 		$139K Buy
49,947
+10,161
+26% +$36.9K ﹤0.01% 2823
2014
Q2 		$162K Sell
39,786
-2,256
-5% -$9.59K ﹤0.01% 2765
2014
Q1 		$223K Buy
42,042
+1,257
+3% +$7.05K ﹤0.01% 2582
2013
Q4 		$226K Buy
40,785
+3,066
+8% +$13.2K ﹤0.01% 2583
2013
Q3 		$170K Buy
37,719
+706
+2% +$3.17K ﹤0.01% 2654
2013
Q2 		$158K Buy
+37,013
New +$186K ﹤0.01% 2612

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock Advisors's SGYP Position: Q4 2016 in Review

BlackRock Advisors increased its Synergy Pharmaceuticals, Inc Common Stock (SGYP) stake by 0.82% in Q4 2016, buying an estimated $5.93K and bringing the position to 140,042 shares worth $853K. The position accounts for ﹤0.01% of the portfolio, ranked #1938.

BlackRock Advisors first reported a position in SGYP in Q2 2013 and has held it in 15 quarters since. 156 funds tracked by Wall St. Rank hold SGYP as of Q4 2016.

  • BlackRock Advisors held 140,042 shares of Synergy Pharmaceuticals, Inc Common Stock worth $853K as of Q4 2016.
  • BlackRock Advisors bought 1,135 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2016, an estimated $5.93K.
  • Synergy Pharmaceuticals, Inc Common Stock made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1938 holding.
  • BlackRock Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and has held it in 15 quarters since.
  • 156 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.